The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.59%Dividend Yield

Mar 26

$0.01

Dec 25

$0.13

Sep 25

$0.18

Jul 25

$0.17

Apr 25

$0.13

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

134.15%

1Y Growth

-20.07%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIB. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ProShares UltraShort Nasdaq Biotechnology -2x Shares

BIS

Mkt Cap0

ProShares UltraShort Nasdaq Biotechnology, offers inverse (-2x) daily performance of the NASDAQ Biotechnology Index, directly competing with BIB's 2x long strategy.

Direxion Daily S&P Biotech Bull 3X

LABU

Mkt Cap0

Direxion Daily S&P Biotech Bull 3X Shares, offers 3x daily long leverage to the S&P Biotechnology Select Industry Index, competing in the leveraged biotech space.

Direxion Daily S&P Biotech Bear 3X

LABD

Mkt Cap0

Direxion Daily S&P Biotech Bear 3X Shares, provides -3x daily short leverage to the same index as LABU, offering an inverse strategy in the leveraged biotech sector.

iShares Biotechnology

IBB

Mkt Cap0

iShares Nasdaq Biotechnology ETF, tracks the NASDAQ Biotechnology Index but without leverage, competing as a more traditional, non-leveraged alternative.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, tracks an equal-weighted index in the biotech sector, offering a diversified non-leveraged alternative.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, provides exposure to companies in the biotech industry, competing as a non-leveraged investment option.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, tracks a modified equal-weighted index of biotech stocks, offering another non-leveraged alternative.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, focuses on small- and mid-cap biotechnology and pharmaceutical companies, offering targeted exposure within the biotech sector.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, uses a quantitative model to select biotech and genome companies, providing a unique strategy within the sector.

Virtus Biotech

BBP

Mkt Cap0

Virtus LifeSci Biotech Products ETF, tracks an equal-weighted index of biotech companies with one or more drugs in Phase III clinical trials, offering focused exposure on late-stage biotech companies.

Holdings

Regions

Sectors

About

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

CEO

Country

United States

ISIN

US74347R2141

Listings

0 Comments

Share your thoughts

FAQ

What is ProShares Ultra Nasdaq Biotechnology 2X Shares stock price today?▼

The current price of BIB is $82.85 USD — it has increased by +0.37% in the past 24 hours. Watch ProShares Ultra Nasdaq Biotechnology 2X Shares stock price performance more closely on the chart.

What is ProShares Ultra Nasdaq Biotechnology 2X Shares stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange ProShares Ultra Nasdaq Biotechnology 2X Shares stocks are traded under the ticker BIB.

Is ProShares Ultra Nasdaq Biotechnology 2X Shares stock price growing?▼

BIB stock has risen by +5.48% compared to the previous week, the month change is a +2.23% rise, over the last year ProShares Ultra Nasdaq Biotechnology 2X Shares has showed a +100.79% increase.

Does ProShares Ultra Nasdaq Biotechnology 2X Shares pay dividends?▼

Yes, BIB dividends are paid quarterly. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 0.59%.

In which sector is ProShares Ultra Nasdaq Biotechnology 2X Shares located?▼

ProShares Ultra Nasdaq Biotechnology 2X Shares operates in the Other sector.

When did ProShares Ultra Nasdaq Biotechnology 2X Shares complete a stock split?▼

The last stock split for ProShares Ultra Nasdaq Biotechnology 2X Shares was on May 20, 2015 with a ratio of 2:1.